CA
NZ
UK
AU
IND
US
• Alaunos Therapeutics (Ticker: TCRT) has attracted renewed attention as a clinical-stage cell-therapy company.
• Hemab Therapeutics (Ticker: COAG) has drawn renewed market interest amid shifting sentiment toward rare-disease biotechnology.
• BillionToOne will occupy approximately 62,659 sq ft of laboratory and office space at 3260 Whipple Road, Union City.
• Cadrenal Therapeutics (NASDAQ: CVKD) appoints John P. Sharp as interim CFO at a flat rate of $455 per hour.
• Lixte Biotechnology (NASDAQ: LIXT) has drawn renewed market interest amid a sharp move in its shares.
• Eikon Therapeutics (NASDAQ: EIKN) has drawn renewed market interest amid attention on drug-discovery technology.
• Polyrizon Ltd (NASDAQ: PLRZ) is a very small Israeli biotech company developing biological-shield and hydrogel-based protective gel concepts.
• 4D Molecular Therapeutics (NASDAQ: FDMT) is a clinical-stage gene therapy company built around an engineered AAV vector platform.
• Universe Pharmaceuticals (UPC) has attracted renewed attention following a pronounced upward move in its share price.
• Decoy Therapeutics (DCOY) has drawn renewed market interest following a notable upward move in its shares.
Please wait processing your request...